| Name | prostate specific antigen |
|---|---|
| Synonyms | NPSA; Prostate specific antigen; novel prostate specific antigen; Prostate specific antigens; novel prostate specific antigens |
| Name | MAA |
|---|---|
| CAS | methylarsonic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 17343337 | Kosanovic MM, Jankovic MM: Sialylation and fucosylation of cancer-associated prostate specific antigen. J BUON. 2005 Apr-Jun;10(2):247-50. |
2(0,0,0,2) | Details |
| 12173328 | Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ: Prostate carcinoma with testicular or penile metastases. Cancer. 2002 May 15;94(10):2610-7. Six of 9 evaluable patients had elevated serum carcinoembryonic antigen levels (> 6 ng/mL), whereas 2 of 10 patients had low or undetectable serum prostate specific antigen levels (< 4 ng/mL). |
1(0,0,0,1) | Details |
| 9267790 | Trachtenberg J: Innovative approaches to the hormonal treatment of advanced prostate cancer. Eur Urol. 1997;32 Suppl 3:78-80. This method reduces the total time of exposure to castrate levels of androgen and, although prostate-specific antigen levels rise during the second phase of therapy suggesting tumor growth, proponents of this cycling method suggest that this should prolong the time to androgen independence of the tumor. |
1(0,0,0,1) | Details |